Flyte Aviation Signs Letter of Intent to Sell Life Sciences Assets
Flyte Aviation (VJET) has entered into a non-binding letter of intent to divest its legacy subsidiary, Catheter Precision. The sale includes the VIVO and LockeT product lines along with related life sciences assets. The strategic move is designed to allow Flyte Aviation to refocus its operations exclusively on the private aviation sector. The proposed transaction will involve cash consideration at closing, subject to customary adjustments, with provisions for potential contingent payments based on future performance.
Topics: Asset Sale Letter of Intent M&A
Read the full article at Seeking Alpha
Part of the story Flyte Aviation plans sale of life sciences assets to focus exclusively on private aviation (2 articles)